First, S100A4TK+ female mice, which express a truncated herpesvirus TK gene under the control of the s100a4 promoter,24 and control S100A4TK− littermates, were implanted with TSA breast cancers treated with or without doxorubicin (figure 3A). This evidence concerns the gene TKT and breast carcinoma.